Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation

Pediatric Blood and Cancer

Volumn 59, Issue 4, 2012, Pages 762-764

  Soni, Sandeep ^a   Skeens, Micah ^a   Termuhlen, Amanda M ^a   Bajwa, Rajinder P S ^a   Gross, Thomas G ^a   Pai, Vinita ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

BMT; Busulfan; Levetiracetam; Seizures

Indexed keywords

BUSULFAN; ETIRACETAM; FOSPHENYTOIN SODIUM; LORAZEPAM;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BEHAVIOR CHANGE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DIFFUSE ALVEOLAR HEMORRHAGE; DRUG COST; DRUG EFFICACY; DRUG MONITORING; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; LIVER VENOOCCLUSIVE DISEASE; LOADING DRUG DOSE; LUNG HEMORRHAGE; MALE; MUCOSA INFLAMMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; BUSULFAN; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; PHENYTOIN; PIRACETAM; SEIZURES; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84864923619     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24126     Document Type: Article

References (20)

1. Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983;309:1347-1353.
2. Shaw PJ, Scharping CE, Brian RJ, et al. Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia. Blood 1994;84:2357-2362.
3. Tran HT, Madden T, Petropoulos D, et al. Individualizing high-dose oral busulfan: Prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies. Bone Marrow Transplant 2000;26:463-470.
4. Vassal G, Gouyette A, Hartmann O, et al. Pharmacokinetics of high-dose busulfan in children. Cancer Chemother Pharmacol 1989;24:386-390.
5. Meloni G, Raucci U, Pinto RM, et al. Pretransplant conditioning with busulfan and cyclophosphamide in acute leukemia patients: neurological and electroencephalographic prospective study. Ann Oncol 1992;3:145-148.
6. Kobayashi R, Watanabe N, Iguchi A, et al. Electroencephalogram abnormality and high-dose busulfan in conditioning regimens for stem cell transplantation. Bone Marrow Transplant 1998;21:217-220.
7. De La Camara R, Tomas JF, Figuera A, et al. High dose busulfan and seizures. Bone Marrow Transplant 1991;7:363-364.
8. Grigg AP, Shepherd JD, Phillips GL. Busulphan and phenytoin. Ann Intern Med 1989;111:1049-1050.
9. Caselli D, Ziino O, Bartoli A, et al. Continuous intravenous infusion of lorazepam as seizure prophylaxis in children treated with high-dose busulfan. Bone Marrow Transplant 2008;42:135-136.
10. Meloni G, Nasta L, Pinto RM, et al. Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patients. Haematologica 1995;80:532-534.
11. Hassan M, Ehrsson H, Wallin I, et al. Pharmacokinetic and metabolic studies of busulfan in rat plasma and brain. Eur J Drug Metab Pharmacokinet 1988;13:301-305.
12. Hassan M, Oberg G, Bjorkholm M, et al. Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics. Cancer Chemother Pharmacol 1993;33:181-186.
13. Ren S, Yang JS, Kalhorn TF, et al. Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes. Cancer Res 1997;57:4229-4235.
14. Anderson GD. A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother 1998;32:554-563.
15. Hamidieh AA, Hamedani R, Hadjibabaie M, et al. Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study. Pediatr Hematol Oncol 2010;27:529-533.
16. Chan KW, Mullen CA, Worth LL, et al. Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplant 2002;29:963-965.
17. Nicolas JM, Collart P, Gerin B, et al. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Drug Metab Dispos 1999;27:250-254.
18. Fitzsimmons WE, Ghalie R, Kaizer H. Anticonvulsants and busulfan. Ann Intern Med 1990;112:552-553.
19. Zwaveling J, Bredius RG, Cremers SC, et al. Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity. Bone Marrow Transplant 2005;35:17-23.
20. Grochow LB, Jones RJ, Brundrett RB, et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989;25:55-61.